Abstract
To study the possible protection or not of Dapaglifozin (SGLT2 inhibitor) in acute kidney injury induced by sepsis in non-diabetic animals. Glomerular and tubular functions will be assessed by creatinine clearance, ion excretion fractions, urinary osmolality, and urinary volume. Background: sepsis is a challenging, heterogeneous and very varied clinical condition, being the main cause of …